17

What is the history of Spinal Muscular Atrophy?

When was Spinal Muscular Atrophy discovered? What is the story of this discovery? Was it coincidence or not?

History of Spinal Muscular Atrophy

Spinal Muscular Atrophy (SMA) is a genetic disorder that affects the motor neurons in the spinal cord, leading to muscle weakness and atrophy. It is one of the most common genetic causes of infant mortality, with an estimated incidence of 1 in 10,000 live births.



The history of SMA dates back to the late 19th century, when French neurologist Aran first described the disease in 1850. He identified a group of children who presented with progressive muscle weakness and atrophy, but the cause of the condition remained unknown for many years.



In the early 20th century, researchers began to recognize the hereditary nature of SMA. In 1900, German neurologist Werdnig described a form of infantile spinal muscular atrophy, now known as SMA type 1 or Werdnig-Hoffmann disease. He observed that the disease was present from birth and led to severe muscle weakness and respiratory difficulties.



Advancements in genetics and molecular biology in the latter half of the 20th century played a crucial role in understanding the underlying cause of SMA. In the 1990s, researchers discovered that SMA is caused by a mutation in the survival motor neuron 1 (SMN1) gene, which is responsible for producing a protein essential for the survival of motor neurons.



Further research revealed that SMA is an autosomal recessive disorder, meaning that an individual must inherit two copies of the mutated SMN1 gene (one from each parent) to develop the disease. Individuals with only one copy of the mutated gene are carriers and do not typically show symptoms.



In recent years, significant progress has been made in the treatment of SMA. In 2016, the U.S. Food and Drug Administration (FDA) approved nusinersen, marketed as Spinraza, as the first-ever treatment for SMA. Nusinersen is an antisense oligonucleotide that targets the SMN2 gene, a closely related gene that produces a less functional form of the SMN protein. By increasing the production of functional SMN protein, nusinersen helps improve motor function in individuals with SMA.



Another breakthrough in SMA treatment came in 2019, when the FDA approved onasemnogene abeparvovec, marketed as Zolgensma, as a gene therapy for SMA. Zolgensma is a one-time intravenous infusion that delivers a functional copy of the SMN1 gene to motor neurons, addressing the underlying genetic cause of SMA.



These advancements in treatment have provided hope for individuals with SMA and their families. Ongoing research continues to explore new therapeutic approaches, including gene editing techniques and other innovative strategies, with the aim of further improving the outcomes and quality of life for individuals affected by this devastating disease.


Diseasemaps
2 answers
Translated from french Improve translation
I know that it is a rare disease, but for the rest you have on wikipedia

Posted Nov 22, 2017 by 2000

History of Spinal Muscular Atrophy

Spinal Muscular Atrophy life expectancy

What is the life expectancy of someone with Spinal Muscular Atrophy?

7 answers
Celebrities with Spinal Muscular Atrophy

Celebrities with Spinal Muscular Atrophy

1 answer
Is Spinal Muscular Atrophy hereditary?

Is Spinal Muscular Atrophy hereditary?

3 answers
Is Spinal Muscular Atrophy contagious?

Is Spinal Muscular Atrophy contagious?

3 answers
Natural treatment of Spinal Muscular Atrophy

Is there any natural treatment for Spinal Muscular Atrophy?

2 answers
ICD9 and ICD10 codes of Spinal Muscular Atrophy

ICD10 code of Spinal Muscular Atrophy and ICD9 code

3 answers
Living with Spinal Muscular Atrophy

Living with Spinal Muscular Atrophy. How to live with Spinal Muscular Atrop...

6 answers
Spinal Muscular Atrophy diet

Spinal Muscular Atrophy diet. Is there a diet which improves the quality of...

8 answers

World map of Spinal Muscular Atrophy

Find people with Spinal Muscular Atrophy through the map. Connect with them and share experiences. Join the Spinal Muscular Atrophy community.

Stories of Spinal Muscular Atrophy

SPINAL MUSCULAR ATROPHY STORIES
Spinal Muscular Atrophy stories
Charlotte & Wayne lost their first daughter Annabelle Rose when she was just 7 months and 12 days old due to a genetic muscle wasting condition called Spinal Muscular Atrophy. Annabelle had Type 1 which is the most severe form of the condition and ta...
Spinal Muscular Atrophy stories
My son Grady was born on May 15th 2015. He wasn't due until June 19th but since I had polyhydraminos my water broke on May 13th. I had noticed while I was pregnant that Grady didn't move near as often or as much as my daughter did during my first pre...
Spinal Muscular Atrophy stories
I was born on March 5, 1949, in a poor neighborhood of Lima, Peru, in a time where most houses had no electricity and radio music was a luxury only afforded by the few. The television had not yet come to the country and Internet was unimaginable. htt...
Spinal Muscular Atrophy stories
My daughter has a SMA type1 , the start of the disease in 5.5 months. She is 17 months. She is breathing on her own. Little holding her head. Raises handle. She begins to talk.
Spinal Muscular Atrophy stories
www.braydensvoyage.com 

Tell your story and help others

Tell my story

Spinal Muscular Atrophy forum

SPINAL MUSCULAR ATROPHY FORUM
Spinal Muscular Atrophy forum
No less than two neurologists have diagnosed me with SMA, but I have to say, I'm pretty sure I DON'T have it. I'm strong, graceful and powerful... the only symptoms I'm experiencing are speech slurring, weak tongue and lips and mild difficulty breat...

Ask a question and get answers from other users.

Ask a question

Find your symptoms soulmates

From now on you can add your symptoms in diseasemaps and find your symptoms soulmates. Symptoms soulmates are people with similar symptoms to you.

Symptoms soulmates

Add your symptoms and discover your soulmates map

Soulmates map